• Starling Oncology 10% owner Jorey Chernett sold 2,851,061 common shares at $3.99 each on November 6, 2026.
• He purchased 48,294 common shares at $3.65 each on November 9, 2026.
• Direct common stock holdings stood at 7,858,091 shares following the transactions.
• Chernett also purchased 29,500 call options covering 2,950,000 common shares from November 6 through November 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Starling Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000921895-26-003018), on November 10, 2026, and is solely responsible for the information contained therein.